GlaxoSmithKline Pharmaceuticals Limited

GLAXONSE · IN

Holders

SBI Midcap Fund
1.5% of their portfolio
₹359.91 Cr
11,80,000 sh
as-of 31 Aug 2026Monthly
Nippon India Pharma Fund
3.1% of their portfolio
₹285.09 Cr
10,29,460 sh
as-of 30 Sept 2026T+30
Nippon India Growth Mid Cap Fund
0.3% of their portfolio
₹154.80 Cr
5,59,000 sh
as-of 30 Sept 2026T+30
SBI Dividend Yield Fund
1.6% of their portfolio
₹137.25 Cr
4,50,000 sh
as-of 31 Aug 2026Monthly
ICICI Prudential Smallcap Fund
0.6% of their portfolio
₹55.76 Cr
2,10,000 sh
as-of 31 Jul 2026Monthly
Aditya Birla Sun Life MNC Fund
1.4% of their portfolio
₹46.41 Cr
1,89,399 sh
as-of 30 Jun 2026Stale
Nippon India Multi Cap Fund
0.1% of their portfolio
₹32.92 Cr
1,18,858 sh
as-of 30 Sept 2026T+30
Aditya Birla Sun Life Multi-Cap Fund
0.3% of their portfolio
₹24.50 Cr
1,00,000 sh
as-of 30 Jun 2026Stale
Aditya Birla Sun Life ELSS Tax Saver Fund
0.1% of their portfolio
₹11.59 Cr
49,585 sh
as-of 30 Apr 2026Stale
Nippon India ETF Nifty Midcap 150
0.3% of their portfolio
₹10.84 Cr
39,145 sh
as-of 30 Sept 2026T+30
Aditya Birla Sun Life Pharma & Healthcare Fund
0.8% of their portfolio
₹7.94 Cr
32,390 sh
as-of 30 Jun 2026Stale
Nippon India Nifty Midcap 150 Index Fund
0.3% of their portfolio
₹7.59 Cr
27,420 sh
as-of 30 Sept 2026T+30

Show all 37 holders

Ownership

FII holding ~flat QoQ

Jun 2026 quarter

Upgrade to see this quarter’s exact figures

Ownership by quarter

Promoter

— 0.0pp

Disclosure timeline

DISCLOSEDT+30
Nippon India Nifty 500 Equal Weight Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
3,274 sh · ₹90.67 L
Filed 30 Sept 2026AMFI portfolioview source
DISCLOSEDT+30
Nippon India Nifty Midcap 150 Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
27,420 sh · ₹7.59 Cr
Filed 30 Sept 2026AMFI portfolioview source
DISCLOSEDT+30
Groww Mutual Fund (scheme IB18)
GlaxoSmithKline Pharmaceuticals Limited · NSE
732 sh · ₹20.27 L
Filed 30 Sept 2026AMFI portfolioview source
DISCLOSEDT+30
Nippon India Multi Cap Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
1,18,858 sh · ₹32.92 Cr
Filed 30 Sept 2026AMFI portfolioview source
DISCLOSEDT+30
ICICI Prudential Quant Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
12,022 sh · ₹3.33 Cr
Filed 30 Sept 2026AMFI portfolioview source
DISCLOSEDT+30
Groww Mutual Fund (scheme IB54)
GlaxoSmithKline Pharmaceuticals Limited · NSE
151 sh · ₹4.18 L
Filed 30 Sept 2026AMFI portfolioview source
DISCLOSEDT+30
Nippon India Growth Mid Cap Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
5,59,000 sh · ₹154.80 Cr
Filed 30 Sept 2026AMFI portfolioview source
DISCLOSEDT+30
ICICI Prudential BSE 500 ETF
GlaxoSmithKline Pharmaceuticals Limited · NSE
747 sh · ₹20.67 L
Filed 30 Sept 2026AMFI portfolioview source

Announcements

The announcements library is part of Pro.

Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.

43 announcements on record for this company.

Part of Pro — upgrade to open